Sound Physicians Of Hawaii Inc - Medicare Primary Care in Kealakekua, HI

Sound Physicians Of Hawaii Inc is a medicare enrolled primary clinic (Internal Medicine) in Kealakekua, Hawaii. The current practice location for Sound Physicians Of Hawaii Inc is 79-1019 Haukapila St, Kealakekua, Hawaii. For appointments, you can reach them via phone at (808) 322-9311. The mailing address for Sound Physicians Of Hawaii Inc is 5410 Maryland Way, Suite 300, Brentwood, Tennessee and phone number is (615) 377-5658.

Sound Physicians Of Hawaii Inc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1740658053. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (808) 322-9311.

Contact Information

Sound Physicians Of Hawaii Inc
79-1019 Haukapila St
Kealakekua
HI 96750-7920
(808) 322-9311
Not Available

Primary Care Clinic Profile

Full NameSound Physicians Of Hawaii Inc
SpecialityInternal Medicine
Location79-1019 Haukapila St, Kealakekua, Hawaii
Authorized Official Name and PositionKelli Queen (DIRECTOR OF PE)
Authorized Official Contact6153775658
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sound Physicians Of Hawaii Inc
5410 Maryland Way
Suite 300
Brentwood
TN 37027-5064

Ph: (615) 377-5658
Sound Physicians Of Hawaii Inc
79-1019 Haukapila St
Kealakekua
HI 96750-7920

Ph: (808) 322-9311

NPI Details:

NPI Number1740658053
Provider Enumeration Date09/03/2015
Last Update Date09/03/2015

Medicare PECOS Information:

Medicare PECOS PAC ID8628378973
Medicare Enrollment IDO20151118002302

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Medical Identifiers

Medical identifiers for Sound Physicians Of Hawaii Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740658053NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Secondary
207R00000XInternal Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Sound Physicians Of Hawaii Inc acts as a billing entity for following providers:
Provider NameInam U Rahman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1619048733
PECOS PAC ID: 4183649718
Enrollment ID: I20051012000473

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJacquelyn Von Murray
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1750479259
PECOS PAC ID: 4183644313
Enrollment ID: I20051201000885

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJames R Madison
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1447231311
PECOS PAC ID: 3779568597
Enrollment ID: I20061025000584

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJoseph H Kamai
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1083700025
PECOS PAC ID: 6204837990
Enrollment ID: I20070123000602

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameConstantin Novoselsky
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1861650764
PECOS PAC ID: 7618038654
Enrollment ID: I20081209000251

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJoseph S Russo
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1891791786
PECOS PAC ID: 2365426376
Enrollment ID: I20090518000318

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameGraham M Cormack
Provider TypePractitioner - Critical Care (intensivists)
Provider IdentifiersNPI Number: 1316058514
PECOS PAC ID: 5395819122
Enrollment ID: I20091001000295

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameYasser Farrag
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1588694475
PECOS PAC ID: 8123049145
Enrollment ID: I20110610000576

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameVinh Truyen Quoc Nguyen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1679693105
PECOS PAC ID: 3870689490
Enrollment ID: I20120326000792

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NamePaul Hayward
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1598907867
PECOS PAC ID: 1355591991
Enrollment ID: I20121017000437

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NamePriscilla Kim Codiga
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1629009402
PECOS PAC ID: 7315926979
Enrollment ID: I20121109000146

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameOlaseni Alexander Shoroye
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1053376509
PECOS PAC ID: 1557346418
Enrollment ID: I20130122000101

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameRyan C Rao
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1962631655
PECOS PAC ID: 8527212745
Enrollment ID: I20130215000314

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameChristy Ann Eubanks
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1477727444
PECOS PAC ID: 3971657412
Enrollment ID: I20130530000723

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJohn A Vidrih
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1063482842
PECOS PAC ID: 2860478617
Enrollment ID: I20130624000242

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameRenato A Reyes
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1245383413
PECOS PAC ID: 0345346441
Enrollment ID: I20131021000070

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameTarek Abdel Shawkat
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801844279
PECOS PAC ID: 7315859550
Enrollment ID: I20131021000102

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameGlenn Banegura
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770744989
PECOS PAC ID: 7315111010
Enrollment ID: I20131114001460

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameNatalie Christina Owens Sloan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1497970479
PECOS PAC ID: 6002901360
Enrollment ID: I20140103001330

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameDavid Hefer
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1174594188
PECOS PAC ID: 0648202689
Enrollment ID: I20140716000010

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameAmjid Muhammad Nawaz
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1720379142
PECOS PAC ID: 1658518519
Enrollment ID: I20150807015690

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJamshid Mirzaei
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1649306523
PECOS PAC ID: 6002964178
Enrollment ID: I20150928000734

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameMichael P Salata
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1275538670
PECOS PAC ID: 2860444098
Enrollment ID: I20151007002027

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameViktor L Corpuz
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1629316914
PECOS PAC ID: 4284941139
Enrollment ID: I20151007002611

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameDeema Jassi
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1255772133
PECOS PAC ID: 9537452016
Enrollment ID: I20160720002413

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameDeborah Ann Volk
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1174574081
PECOS PAC ID: 4880596311
Enrollment ID: I20160906002563

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameAndres G Zuleta
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1396059150
PECOS PAC ID: 1759521388
Enrollment ID: I20160915002341

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameKristin A Childers
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1790943348
PECOS PAC ID: 4880867597
Enrollment ID: I20170224001815

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameRoberto Sanchez Gutierrez
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1164625182
PECOS PAC ID: 6608064472
Enrollment ID: I20170726003314

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameMichelle A Tenorio
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1962815951
PECOS PAC ID: 1254605652
Enrollment ID: I20170925000721

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameNicolai Wohns
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1801207279
PECOS PAC ID: 3072732452
Enrollment ID: I20171002001569

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameKari M Dechenne
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1306045331
PECOS PAC ID: 7719059682
Enrollment ID: I20171006001132

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameNadine Aldahhan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1609202308
PECOS PAC ID: 6901024009
Enrollment ID: I20171208000472

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJane J Park
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1790129898
PECOS PAC ID: 5799044293
Enrollment ID: I20180108002716

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJohn R Kercheval
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1659458842
PECOS PAC ID: 7618069410
Enrollment ID: I20181212001828

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameAndrew Meillier
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1033520325
PECOS PAC ID: 1658660402
Enrollment ID: I20190114000614

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameQuynh-lan Nguyen
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1184064149
PECOS PAC ID: 1951697895
Enrollment ID: I20190116001507

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameBen B Mousavi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1003230079
PECOS PAC ID: 9032433057
Enrollment ID: I20190220003459

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameKristin Heather King
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1518346717
PECOS PAC ID: 4284997586
Enrollment ID: I20190607001567

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameHassan Barazi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1972777217
PECOS PAC ID: 4486825080
Enrollment ID: I20190717000364

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameWesam W Agha
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1700273554
PECOS PAC ID: 4880954130
Enrollment ID: I20190904001556

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameScott M Lawler
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1508228115
PECOS PAC ID: 5496049090
Enrollment ID: I20191219001719

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameDaniel John Spiger
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1912297011
PECOS PAC ID: 3072757350
Enrollment ID: I20200115001329

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameLeah M Grabenauer
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1760740385
PECOS PAC ID: 7810124070
Enrollment ID: I20200211002940

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameLauren F Thom
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1982055851
PECOS PAC ID: 2466746722
Enrollment ID: I20200324001159

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameEric Richmond Fenn
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1215386966
PECOS PAC ID: 5597050146
Enrollment ID: I20200825001232

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJena Uvalle
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1407376098
PECOS PAC ID: 7517231459
Enrollment ID: I20200908001039

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameSteven Kwon
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1073765400
PECOS PAC ID: 1557530615
Enrollment ID: I20201019001825

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameNirmal B Singh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1194799288
PECOS PAC ID: 9739072893
Enrollment ID: I20201119000840

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameLisa Tharler
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801852587
PECOS PAC ID: 5092051029
Enrollment ID: I20210422002475

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJohn Wesley Neighbors
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1629506233
PECOS PAC ID: 1355744178
Enrollment ID: I20210730000554

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameEleazar Quintanilla
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1518126309
PECOS PAC ID: 5597822494
Enrollment ID: I20211115002718

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameNicole Nazemi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1962906610
PECOS PAC ID: 3678964954
Enrollment ID: I20211221000905

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameChristopher Deuel
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1932545035
PECOS PAC ID: 7719204197
Enrollment ID: I20220511000184

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameUmar Bhatti
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1558802751
PECOS PAC ID: 3577897529
Enrollment ID: I20220825004030

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameJacob Lebeau
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1518457985
PECOS PAC ID: 2567899172
Enrollment ID: I20230717001463

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameSarah Al-nuaimi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1801354667
PECOS PAC ID: 0143675389
Enrollment ID: I20231009001720

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameHassan A Elhewan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1457668139
PECOS PAC ID: 5991947038
Enrollment ID: I20231027001529

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NamePreetivi Ellis
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1538471305
PECOS PAC ID: 9032334644
Enrollment ID: I20231030003612

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameAmanda Lynn Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1245457670
PECOS PAC ID: 6800035692
Enrollment ID: I20231101002667

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameTara Rose Buschor
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1689022642
PECOS PAC ID: 4385939909
Enrollment ID: I20231113003410

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameSteven Carl Nuanes
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1922413285
PECOS PAC ID: 5193094357
Enrollment ID: I20231120001233

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameShmyra Fountain
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609652262
PECOS PAC ID: 3971953142
Enrollment ID: I20231229002395

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameStephanie Yoshimura
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1689038796
PECOS PAC ID: 6305217928
Enrollment ID: I20240115001659

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

Provider NameRobert Emmett O'connor Iii
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1710103270
PECOS PAC ID: 8123126984
Enrollment ID: I20240118001957

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more Medical News

› Verified 5 days ago

News Archive

PPR proteins recognise RNA targets via easy-to-understand code

The code determines the recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins.

New review recommends a holistic approach to manage cerebral small vessel disease

Cerebral small vessel disease (SVD) is characterized by damage to the blood vessels and parenchyma in the brain. It presents as a multitude of symptoms, which makes the diagnosis difficult.

Research finds sex ratios influence financial decisions

The perception that women are scarce leads men to become impulsive, save less, and increase borrowing, according to new research from the University of Minnesota's Carlson School of Management.

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer Inc. announced this Tuesday that its oral multi-kinase inhibitor Sutent was determined as having a favorable benefit-risk profile by an oncology advisory committee of the FDA for the treatment of unresectable pancreatic neuroendocrine tumors. The panel voted 8-2 in favor of Sutent – generically called Sunitib malate.

Researchers receive $13 million NIH grant to develop new stem cell-based assays for studying autism

The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.

Read more News

› Verified 5 days ago


Internal Medicine in Kealakekua, HI

Hospitalist Medicine Physicians Of Hawaii-tcg, Inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 79-1019 Haukapila St, Kealakekua, HI 96750
Phone: 808-322-9311    Fax: 808-322-4488
West Hawaii Community Health Center, Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 81-980 Halekii St Ste 103, Kealakekua, HI 96750
Phone: 808-326-3878    
Clif Arrington M.d., Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 79-7266 Mamalahoa Hwy, Suite 3, Kealakekua, HI 96750
Phone: 808-322-9400    Fax: 808-324-7522
West Hawaii Community Health Center, Inc. - Kealakekua Adult & Family
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 81-980 Halekii St Ste 107, Kealakekua, HI 96750
Phone: 808-326-3883    
Hawaii Family Physicians
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 81-6587 Mamalahoa Hwy C201, Kealakekua, HI 96750
Phone: 808-323-3107    Fax: 808-323-0012
Sukchai Satta Md, Inc.
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 79-7266 Mamalahoa Hwy, Suite 2, Kealakekua, HI 96750
Phone: 808-322-9324    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.